Description
Release form
tablets
Packing
50 pcs.
Pharmacological action
The spectrum of action of Pantogam ® is associated with the presence of gamma-aminobutyric acid (GABA) in its structure. The mechanism of action is due to the direct effect of the drug on the GABAA-receptor-channel complex.
Has a nootropic and anticonvulsant effect. Increases brain resistance to hypoxia and toxic substances, stimulates anabolic processes in neurons, combines moderate sedative effect with a mild stimulating effect, reduces motor excitability, activates mental and physical performance.
Improves the metabolism of GABA in chronic alcohol intoxication and after discontinuation of ethanol.
Able to inhibit acetylation reactions involved in the inactivation of procaine (novocaine) and sulfonamides, due to which the prolongation of the action of the latter is achieved. Causes inhibition of pathologically increased cystic reflex and detrusor tone.
Pharmacokinetics
Pantogam ® is rapidly absorbed from the gastrointestinal tract, passes through the BBB, and the highest concentrations are created in the liver, kidneys, stomach wall and skin. It is not metabolized and excreted unchanged within 48 hours: 67.5% of the dose taken is excreted in the urine, 28.5% – with feces.
Contraindications
hypersensitivity
acute severe kidney disease
pregnancy (I trimester – syrup)
pregnancy (tablets)
phenylketonuria (syrup, contains aspartame)
period of breastfeeding (tablets).
children’s age up to 3 years (tablets).
Special instructions
Information about the possible effect of the drug on the ability to drive vehicles and mechanisms.
In the first days of admission, care should be taken when driving vehicles and mechanisms, given the possible occurrence of drowsiness
Composition
Active ingredient:
calcium hopantenate (Pantogam ®) 500 mg
Excipients: srdlkrd cellulose stearate,
magnesium hydroxycarbonate,
talc
Dosage and administration of
Adults: single dose – 0.251 g, daily – 1.53 g for children: single dose – 0.250.5 g, daily – 0.753 g. The course of treatment is 14 months, in some cases – up to 6 months. After 3-6 months, a second course of treatment is possible.
With epilepsy in combination with anticonvulsants – 0.751 g / day. The course of treatment is up to 1 year or more.
In extrapyramidal neuroleptic syndrome in combination with the therapy, the daily dose is up to 3 g, treatment for several months.
In extrapyramidal hyperkinesis in patients with hereditary diseases of the nervous system (combined treatment) – 0.53 g / day. The course of treatment is up to 4 months or more.
With the consequences of neuroinfections and head injury – 0.25 g 3-4 times a day.
To restore performance under increased loads and asthenic conditions – 0.25 g 3 times a day.
For the treatment of extrapyramidal syndrome caused by the use of antipsychotics, adults – 0.5-1 g 3 times a day for children – 0.25-0.5 g 3-4 times a day. The course of treatment is 1-3 months.
For tics: children – 0.250.5 g 36 times a day, for 14 months.
For disorders of urination: adults – 0, 5-1 g 2-3 times a day for children – 0.25-0.5 g (daily dose – 25-50 mg / kg). The course of treatment is 1-3 months.
For children with various pathologies of the nervous system, depending on age, the drug is recommended at a dose of 1-3 g. Tactics of prescribing the drug: increasing the dose for 7-12 days, taking the maximum dose for 15-40 days and gradually reducing the dose to Pantogam® withdrawal within 78 days. The break between Pantogam® course receptions, as for any other nootropic remedy, is from 1 to 3 months.
Side effects
Allergic reactions: rhinitis, conjunctivitis, skin rashes are possible.
Others: sleep disturbances or drowsiness are possible, tinnitus (these symptoms are usually short-term and do not require discontinuation of the drug).
Drug interaction
It prolongs the action of barbiturates, enhances the action of anticonvulsants, prevents side effects of phenobarbital, carbamazepine, antipsychotics.
Potentiates the action of local anesthetics (procaine).
The effect of Pantogam ® is enhanced in combination with glycine, ethidronic acid (xidiphon).
Overdose
Symptoms: increased symptoms of side effects (sleep disturbance or drowsiness, noise in the head).
Treatment: administration of activated carbon, gastric lavage, symptomatic therapy.
Storage Conditions
The product should be stored in a dark place at 15 ° C to 20 ° C.
Term hodnosty
3 years
active substance
hopantenic acid
Terms leave around drugstore
prescription
lekarstvennaja form
tablets
